Why is Arvee Laborat. falling/rising?

As of 26-Sep, Arvee Laboratories (India) Ltd is experiencing a decline in its stock price, currently at 165.34, which reflects a decrease of 7.16 points or 4.15%. The stock has underperformed its sector today by 2.16%, and its delivery volume has significantly decreased by 75.82% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has dropped by 6.61%, while it has shown a modest increase of 2.83% over the past month. However, its year-to-date performance remains negative at -4.85%. The company has a low debt-to-equity ratio, but it faces challenges such as poor long-term growth, with operating profit increasing at only 1.80% annually over the last five years, and negative results reported in June, including a substantial drop in net sales and profits.
In the broader market context, the Sensex has declined by 2.65% over the past week, which is less than the stock's decline, suggesting that the stock is underperforming relative to the market. While the stock has shown strong performance over longer periods, such as a 75.99% increase over three years and a remarkable 364.11% rise over five years, its recent performance has been disappointing, with a -6.85% return over the past year. The stock is currently trading at a premium compared to its peers, with a high price-to-book value of 5.8, which may deter investors amid falling profits. Overall, the combination of negative financial results, declining investor interest, and a high valuation relative to peers contributes to the stock's downward movement.